MDMA, the active ingredient in ecstasy, allows participants to experience the opposite of their PTSD symptoms, ideally increasing trust and dampening fear. Participants go through 3 previous therapy visits to establish a baseline and get them familiar with the therapy process, then they have their first MDMA session, followed by 3 integrative sessions, their second MDMA session, 3 more integrative sessions, and then their final MDMA session and 3 integrative sessions. Overall, the therapy sessions span 12-15 weeks, and though the courses are quite intense, participants have found this method to be less invasive and retraumatizing than their previous experiences with talk therapy.
During their MDMA sessions, participants will spend 8 hours with 2 therapists who will guide the participant to follow their inner process by listening to their internal healing intelligence. This could mean that the participant talks a lot or barely at all during the session, but the purpose of the subsequent integrative visits is to help the participant process what they experienced and develop the new perspectives that they may be feeling in terms of life in general, coping with their trauma, work, and relationships.
The MAPS research group’s research has shown that 2 months after completing their last therapy session, 56% of participants no longer had PTSD, while 12 months after finishing their therapy, 68% no longer had PTSD. Participants have been pleasantly surprised by their results and healing, and therapists are observing the sessions and effects have been amazed at its effectiveness.
To anyone who has been seeking help and been discouraged with your progress, Amy and Shannon want you to know that there is hope and research advances are providing new treatment options to the field faster than ever before. Keep seeking help until you find the right fit for you.
Connect with Amy and Shannon: